Total Intravenous Anesthesia (TIVA) and Target Controlled Infusion
Total intravenous anaesthesia (TIVA) gives anaesthesia entirely through the vein, usually with propofol and an opioid. Target-controlled infusion (TCI) uses computer-controlled pumps and drug models to reach and hold a chosen drug level in the body.
The Total Intravenous Anesthesia (TIVA) and Target Controlled Infusion session at WSAC 2027 covers TIVA science and practice. It connects closely with modern anesthesia practices and anesthetic drug advances, which looks at new anaesthetic drugs.
TIVA gives all anaesthetic drugs through a drip rather than as gases. Computer-controlled pumps can keep drug levels steady. TIVA can reduce sickness after surgery and support nerve monitoring. It is also gaining attention as a lower-carbon choice.
Key Topics in Total Intravenous Anesthesia (TIVA) and Target Controlled Infusion
• Principles of TIVA
• Pharmacokinetic and pharmacodynamic models
• Target-controlled infusion systems
• TIVA in day-case surgery
• TIVA and postoperative nausea
• TIVA in children and older adults
• Depth of anaesthesia monitoring with TIVA
• Closed-loop anaesthesia
• Environmental benefits of TIVA
• Training and safety in TIVA
Recent Advances in Total Intravenous Anesthesia (TIVA) and Target Controlled Infusion
TIVA is growing as departments seek to cut the carbon footprint of anaesthetic gases. Closed-loop systems that adjust drug delivery automatically using brain signals from neuroanesthesia and brain monitoring are being tested.
TIVA is especially useful in neurosurgery and spine surgery, where it supports nerve monitoring. New models are improving dosing in children and older adults, covered in pediatric, geriatric and high risk anesthesia.
Better drug models are improving dosing in children, older adults and obese patients. Closed-loop systems that adjust doses automatically are being tested. Departments are training more staff in TIVA techniques. Research is comparing outcomes with gas-based anaesthesia.
Who Should Attend the Total Intravenous Anesthesia (TIVA) and Target Controlled Infusion Session
• Anaesthesiologists and anaesthetists
• Anaesthesia trainees
• Pharmacologists
• Biomedical engineers
• Researchers
• Infusion pump manufacturers
Why Present Your Research in Total Intravenous Anesthesia (TIVA) and Target Controlled Infusion
Presenting at WSAC 2027 lets you share TIVA research with an international audience. You can connect with colleagues in general anesthesia: innovations and risk management improving anaesthesia safety. TIVA use is growing worldwide. Sharing your experience here helps others adopt it safely.
Frequently Asked Questions
Can I present closed-loop anaesthesia research?
Yes. Closed-loop systems are a key topic.
Does this session cover TIVA in children?
Yes. TIVA in children and older adults is welcome.
Where is WSAC 2027?
WSAC 2027 is held at Village Hotel Changi, Singapore, from 11 to 13 March 2027, with online participation.